Acute encephalitis, myoclonus and Sweet syndrome after mRNA-1273 vaccine.
A patient presented with fever, generalised rash, confusion, orofacial movements and myoclonus after receiving the first dose of mRNA-1273 vaccine from Moderna. MRI was unremarkable while cerebrospinal fluid showed leucocytosis with lymphocyte predominance and hyperproteinorrachia. The skin evidenced red, non-scaly, oedematous papules coalescing into plaques with scattered non-follicular pustules. Skin biopsy was consistent with a neutrophilic dermatosis. The patient fulfilled the criteria for Sweet syndrome. A thorough evaluation ruled out alternative infectious, autoimmune or malignant aetiologies, and all manifestations resolved with glucocorticoids. While we cannot prove causality, there was a temporal correlation between the vaccination and the clinical findings.
Duke Scholars
Published In
DOI
EISSN
Publication Date
Volume
Issue
Location
Related Subject Headings
- Sweet Syndrome
- Myoclonus
- Humans
- Encephalitis
- COVID-19 Vaccines
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 2019-nCoV Vaccine mRNA-1273
- 1103 Clinical Sciences
Citation
Published In
DOI
EISSN
Publication Date
Volume
Issue
Location
Related Subject Headings
- Sweet Syndrome
- Myoclonus
- Humans
- Encephalitis
- COVID-19 Vaccines
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 2019-nCoV Vaccine mRNA-1273
- 1103 Clinical Sciences